DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Barosi G, Tefferi A, Besses C, Birgegard G, Cervantes F, Finazzi G. et al.
Clinical end points for drug treatment trials in BCR-ABL1-negative classic myeloproliferative neoplasms: Consensus statements from European Leukemia Net (ELN) and Internation Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT).
Leukemia 2015;
29: 20-6
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.